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Background
Alström syndrome (ALMS) is a rare autosomal recessive
genetic disorder characterised by progressive endocrine
disarray, sensorineural deficit, cardiac, renal, and hepatic
abnormalities. Idiopathic infantile dilated cardiomyopa-
thy (CMP) is common, presenting acutely in 45% of
individuals and recurs or develops de novo in 65% of
adolescents with high rates of morbidity and mortality.
Myocardial fibrosis has been demonstrated at post-mor-
tem and on MRI with patchy diffuse late gadolinium
enhancement (LE) in an older cohort of ALMS patients.
We hypothesise that subclinical diffuse fibrosis in young
patients with ALMS precedes any change in conven-
tional parameters of ventricular function or overt scar-
ring on LE.
Methods
Thirteen patients (mean age 27 +/- 11 years, 77% male,
prevalence infantile CM 15%) from the National Specia-
list Commissioning Group for Alström Syndrome, Bir-
mingham, UK and matched age and gender controls
were prospectively assessed with 2D echocardiography
and cardiac MRI (1.5T). Late gadolinium enhancement
images were acquired 5-7 minutes after contrast. Myo-
cardial extracellular volume (ECV) was assessed using
T1-mapping pre and 15 minutes post gadolinium
(0.1mmol/Kg) using a modified look-locker inversion
recovery sequence (MOLLI) (Figures 1 &2). Myocardial
T1 was measured in the basal and mid septum avoiding
areas of LE.
Results
Septal myocardial ECV was increased in female ALMS
compared to male ALMS (0.27 +/- 0.02 vs. 0.31 +/-
0.02, p<0.05). Septal myocardial ECV was increased in
ALMS compared to controls (0.26 +/- 0.02 vs. 0.29 +/-
0.03, p<0.05). Three male older ALMS patients (mean
43 +/- 5 years vs. 27 +/- 10 years) all without a history
of infantile CMP, had patchy diffuse LE in non-coronary
artery territories with an increased ECV compared to
remote “normal” myocardium (ECV 0.41 +/- 0.08 vs.
0.27 +/- 0.03, p<0.05). There were no differences in
mean LV mass, LV ejection fraction or LA volume
between ALMS and controls. Increased septal myocar-
dial ECV correlated with a reduction in lateral and
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Figure 1 Pre-contrast MOLLI with the regions of interest drawn in
the basal and mid septum and descending aorta
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septal TDI systolic velocities (r = -0.82, p<0.05, r =
-0.81, p<0.05). NT-BNP was not correlated with septal
ECV but was increased in patients with LGE (median
178 pmol/L vs. 44 pmol/L).
Conclusions
Patients with ALMS demonstrate a spectrum of myocar-
dial fibrosis, which correlates with reduced longitudinal
contractility before changes in conventional markers of
LV structure and function. This precedes a clinically sig-
nificant increase in BNP that appears with overt LE and
suggests that increased ECV may be a target for early
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Figure 2 MOLLI 15 minutes after contrast with the regions of
interest drawn in the basal and mid septum and descending aorta
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